Literature DB >> 16696313

Polylactic acid nanoparticles targeted to brain microvascular endothelial cells.

Huafang Wang1, Yu Hu, Wangqiang Sun, Changsheng Xie.   

Abstract

In this work, blank polylactic acid (PLA) nanoparticles with unstained surface were prepared by the nano-deposition method. On the basis of the preparation, the effect of surface modification on brain microvascular endothelial cells (BMECs) targeting was examined by in vivo experiments and fluorescence microscopy. The results showed that PLA nanoparticles are less toxic than PACA nanoparticles but their BMECs targeting is similar to PACA nanoparticles. The experiments suggest that drugs can be loaded onto the particles and become more stable through adsorption on the surface of PLA nanoparticles with high surface activity. The surface of PLA nanoparticles was obviously modified and the hydrophilicity was increased as well in the presence of non-ionic surfactants on PLA nanoparticles. As a targeting moiety, polysobate 80 (T-80) can facilitate BMECs targeting of PLA nanoparticles.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16696313     DOI: 10.1007/bf02896158

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  8 in total

Review 1.  Gene-transfer systems for human endothelial cells. stewart.martin@nottingham.ac.uk.

Authors:  S G Martin; J C Murray
Journal:  Adv Drug Deliv Rev       Date:  2000-03-30       Impact factor: 15.470

2.  The fate of biodegradable microspheres injected into rat brain.

Authors:  Anthony P Nicholas; Carey McInnis; Kiran B Gupta; William W Snow; Darryl F Love; David W Mason; Teresa M Ferrell; Jay K Staas; Thomas R Tice
Journal:  Neurosci Lett       Date:  2002-04-26       Impact factor: 3.046

3.  Gene targeting technology and gene therapy of the brain.

Authors:  W Pardridge
Journal:  Drug Discov Today       Date:  2001-02-01       Impact factor: 7.851

4.  Toxicological studies of doxorubicin bound to polysorbate 80-coated poly(butyl cyanoacrylate) nanoparticles in healthy rats and rats with intracranial glioblastoma.

Authors:  S E Gelperina; A S Khalansky; I N Skidan; Z S Smirnova; A I Bobruskin; S E Severin; B Turowski; F E Zanella; J Kreuter
Journal:  Toxicol Lett       Date:  2002-01-25       Impact factor: 4.372

Review 5.  Nanoparticulate systems for brain delivery of drugs.

Authors:  J Kreuter
Journal:  Adv Drug Deliv Rev       Date:  2001-03-23       Impact factor: 15.470

6.  'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption.

Authors: 
Journal:  Colloids Surf B Biointerfaces       Date:  2000-10-01       Impact factor: 5.268

7.  Biodistribution of fluoresceinated dextran using novel nanoparticles evading reticuloendothelial system.

Authors:  U Gaur; S K Sahoo; T K De; P C Ghosh; A Maitra; P K Ghosh
Journal:  Int J Pharm       Date:  2000-07-20       Impact factor: 5.875

8.  Specific role of polysorbate 80 coating on the targeting of nanoparticles to the brain.

Authors:  Wangqiang Sun; Changsheng Xie; Huafang Wang; Yu Hu
Journal:  Biomaterials       Date:  2004-07       Impact factor: 12.479

  8 in total
  1 in total

1.  Composite polylactic-methacrylic Acid copolymer nanoparticles for the delivery of methotrexate.

Authors:  Bongani Sibeko; Yahya E Choonara; Lisa C du Toit; Girish Modi; Dinesh Naidoo; Riaz A Khan; Pradeep Kumar; Valence M K Ndesendo; Sunny E Iyuke; Viness Pillay
Journal:  J Drug Deliv       Date:  2012-07-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.